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Genetic networks controlling retinal injury
Felix R. Vazquez-Chona,1 Amna N. Khan,1 Chun K. Chan,1 Anthony N. Moore,2 Pramod K. Dash,2 M. Rosario
Hernandez,3 Lu Lu,4 Elissa J. Chesler,5 Kenneth F. Manly,4 Robert W. Williams,4 Eldon E. Geisert, Jr.1
1
Department of Ophthalmology, The Hamilton Eye Institute and 4Center of Genomics and Bioinformatics, University of Tennessee
Health Science Center, Memphis, TN; 2Department of Neurobiology and Anatomy, The Vivian L. Smith Center for Neurologic
Research, University of Texas Medical School, Houston, TX; 3Department of Ophthalmology and Visual Sciences, Washington
University School of Medicine, St. Louis, MO; 5Life Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN

Purpose: The present study defines genomic loci underlying coordinate changes in gene expression following retinal
injury.
Methods: A group of acute phase genes expressed in diverse nervous system tissues was defined by combining microarray
results from injury studies from rat retina, brain, and spinal cord. Genomic loci regulating the brain expression of acute
phase genes were identified using a panel of BXD recombinant inbred (RI) mouse strains. Candidate upstream regulators
within a locus were defined using single nucleotide polymorphism databases and promoter motif databases.
Results: The acute phase response of rat retina, brain, and spinal cord was dominated by transcription factors. Three
genomic loci control transcript expression of acute phase genes in brains of BXD RI mouse strains. One locus was
identified on chromosome 12 and was highly correlated with the expression of classic acute phase genes. Within the locus
we identified the inhibitor of DNA binding 2 (Id2) as a candidate upstream regulator. Id2 was upregulated as an acute
phase transcript in injury models of rat retina, brain, and spinal cord.
Conclusions: We defined a group of transcriptional changes associated with the retinal acute injury response. Using
genetic linkage analysis of natural transcript variation, we identified regulatory loci and candidate regulators that control
transcript levels of acute phase genes.

genes involved in neuronal and glial structural remodeling.
Similar changes were described in injury models in the rat
retina [2-5], brain [6,7], and spinal cord [8]. For example, the
early acute genes Fos, Jun, Egr1, and Nfkb1 as well as the late
chronic genes Gfap, A2m, Apoe, and Hsp27 display transcript
changes resulting from virtually any trauma or stress throughout the CNS [1-8]. The similarities of coordinate changes in
the retina, brain, and spinal cord indicate the presence of common transcriptional networks controlling the CNS response
to injury.
GeneNetwork [9-12] is a powerful analytical tool to define transcriptional networks and regulators in CNS tissues.
At the heart of this analysis is a unique population of mice,
the recombinant inbred (RI) strains of mice. These strains were
derived by inbreeding for over 20 generations the F1 crosses
between C57BL/6 (B) and DBA/2J (D) mouse strains. Each
BXD RI strain has a shuffled genome consisting of a unique
recombination of the C57BL/6 and DBA/2J genomes, forming a segregating population of mice. These RI mouse strains,
the associated microarray databases, and the genetic-analysis
tools at GeneNetwork allow one to explore regulatory loci
and networks built around any transcript [9-12]. The best way
to think about the genetic linkage mapping is at the transcript
level. If there is specific variability in transcript abundance
among members of a segregating population, then it is possible to map transcript abundance to a specific chromosomal
locus [9,10]. One example of this type of analysis was presented by Chesler and colleagues [9] where a group of genes
involved in synaptic vesicle regulation forms a network with

To understand the global consequences of retinal injury,
several laboratories monitored the transcriptome with
microarray techniques [1-5]. These changes in transcripts were
analyzed to define the key regulatory events following retinal
injury. In an earlier study, we defined a temporal grouping of
changes related to the biochemical and cellular response to
retinal injury [1]. This type of analysis, defining gene clusters
that occur after injury, is not an endpoint in the analysis but a
beginning. The growing number of bioinformatic resources
provides an opportunity to further analyze and interpret the
changes in the transcriptome after retinal injury. We can now
examine the transcriptome data from injured retina by using
not only various injury models [1-5] but also combining data
from different regions of the central nervous system (CNS [69]).
Our previous analysis of rat retina identified three major
transcript phases after injury: an early acute phase (within an
hour), an intermediate subacute phase (within 1 to 2 days),
and a late chronic phase (within 3 days to weeks [1]). The
early acute phase is characterized by the transient upregulation
of immediate-early genes, mainly transcription factors and
activating cytokines. The intermediate subacute phase is characterized by the expression of cell-cycle and cell death genes.
The late chronic phase is characterized by the expression of
Correspondence to: Eldon E. Geisert, Jr., Department of Ophthalmology, University of Tennessee Health Science Center, 930 Madison Avenue, Suite 731, Memphis, TN, 38163; Phone: (901) 448-7740;
FAX: (901) 448-5028; email: egeisert@utmem.edu
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distinct regulatory loci. The concept of genetic analysis of transcript data is called “expression genetics” or “genetical
genomics” [13]. Of interest to the vision community is the
comprehensive analysis of regulatory loci controlling gene
expression of the mouse brain. Both retina and brain are tissues derived from the neural tube. Thus, they share similar
cell types with similar transcriptional regulation. For example,
the transcription factor STAT3 plays an important role in activating cortical astrocytes [14] and retinal Müller glial cells
[15]. Thus, it may be possible to use available genetic analyses of brain transcript data to define genetic networks and regulatory loci for the rat retina. To identify genomic loci and potential candidate genes controlling changes in the rat retina,
we turned to our publicly available database, GeneNetwork.
The GeneNetwork database was generated using RI mouse
strains and a similar data set is not currently available for the
rat. Since the rat is closely related to the mouse and since transcriptional expression in the normal and injured CNS is highly
conserved across rodent species [16], we have chosen to use
this mouse database to further analyze the changes in gene
expression that occur following injury to the rat CNS.
Here we describe a method to define regulators of retinal
wound healing that uses published and publicly available
microarray data, transcript regulatory loci databases, and
bioinformatic resources. As a starting point, we define regulators that control the expression of acute phase genes after a
mechanical injury to the rat retina [1]. First, to eliminate retinaspecific genes and to increase the power of our analysis, we
extract a group of acute phase genes that are common to injured rat retina, brain, and spinal cord. Second, we determine
the regulatory loci controlling the expression of acute phase
genes in mouse brains using GeneNetwork. Third, we use computational tools to predict a candidate upstream regulator.

tensity to 8 as described previously [1]. These transformations
yielded signal intensities ranging from 1 to 18 relative units
of fluorescence. Further analyses included only transcripts with
medium to high abundance (that is, signals greater than 8.64)
[1]. To determine significant differences, we used Student’s ttest (p<0.05) and changes greater than 2 fold. The second metaanalysis determined if an acute phase gene was expressed in
cultured astrocytes, cultured microglia, cultured neurons, and
in the developing retina. An acute gene was considered present
in a tissue if it displayed medium to high abundance [1]. In
the third meta-analysis, we used GeneNetwork to examine transcript regulation in mouse forebrains. Transcriptome analyses
with Affymetrix RG-U34A and MG-U74Av2 survey about
nine and twelve thousand targets (about 30 and 40% of the
rodent transcriptome, Affymetrix database, June 2005 Annotation).
Online regulatory locus analyses: To define regulatory
loci that control gene expression in mouse brain, we used
GeneNetwork, which is maintained by members of our group
(EJC, LL, KFM, and RWW). Details on the methods, data,
and analyses are available at GeneNetwork [9-12]. Briefly,
GeneNetwork is a suite of databases and analysis software
that identifies regulatory loci that control transcript abundance
of nearly 12,000 genes in a panel of 32 BXD RI mouse strains
derived from C57BL/6 (B) and DBA/2J (D) mice, both parental strains, and the F1 hybrid (a total of 35 isogenic lines)
[9-12]. Strain means for transcript abundance were generated
from three to five Affymetrix U74Av2 microarrays, and each
individual array was hybridized to a pool of forebrain tissue
taken from three adult animals [9,11]. To maximize straindependent expression variance or heritability, probe-set signals were measured by weighting the perfect-match (PM)
probes by their heritability [22]. Using quantitative genetic
analysis and a genetic map consisting of 779 fully genotyped
markers, GeneNetwork correlates the mean abundance of each
transcript to genotypes at locations throughout the mouse genome. The average distance between adjacent markers is approximately 4 megabases (Mb). Here, we examined the regulation of acute phase genes in mouse brains using
GeneNetwork and the weighted-by-heritability transforms
(UTHSC Brain mRNA U74Av2 HWT1PM; December 2003).
Variability across strains was measured using an analysis of
variance (ANOVA) testing the between-strain variance compared with the total variance for 100 arrays from 35 mouse
strains. The degrees of freedom for the between-group and
total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when F34,99>1.5. Whole genome maps for all
transcripts are replicated and recomputed using a variety of
transforms and analytical methods in GeneNetwork, including simple and composite interval mapping, multiple-trait clustering, and principal component analysis. We also confirmed
the strength of a candidate upstream regulator using the cerebellum GeneNetwork database (SJUT Cerebellum mRNA
M430 MAS5; January 2004). Since gene names may differ
across species and multiple probe sets may be available in the
U74Av2 microarray, we include the probe set identifier when
referring to genes analyzed with GeneNetwork. We confirmed

METHODS
Meta-analyses of microarray data sets: We performed a metaanalysis of previous experimental data (Table 1) to select a
group of candidate genes for a common response to injury in
neural tissues. We previously published CNS microarray analyses that examined the transcriptome response of injured rat
retina and brain, the transcriptome of cultured human and rat
astrocytes, and the regulatory loci controlling transcript expression in the mouse brain [1,6,7,9,11,17]. To complement
our analysis of reactive CNS genes, we obtained publicly available microarray analyses that examined the transcriptome response of injured rat spinal cord, the transcriptome of developing mouse retina, and the transcriptome of cultured mouse
neurons, mouse astrocytes, and rat microglia [8,18-21]. Table
1 makes clear the source and availability of each microarray
data set. The use of microarray datasets involved three different meta-analyses. First, a set of acute phase genes commonly
expressed throughout the CNS was defined by directly comparing microarray data from injured rat retina, brain, and spinal cord. For this analysis, we obtained the raw data (CEL
files), determined signal values using Microarray Suite 5.0
(MAS 5.0; Affymetrix, Santa Clara, CA), transformed signals
to a log scale (base 2), and normalized microarray mean in959
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gene identity of a probe set using the Affymetrix (June 2005
Annotation) and Ensembl AffyProbe (v33) databases.
Online bioinformatic resources: To identify candidate
genes within a regulatory locus, we located genes within the
appropriate genomic interval using the Genome Browser
(GenomeBrowser) Mouse (May 2004 assembly). Single nucleotide polymorphisms (SNPs) were identified by comparing
genome sequences in the Celera SNP (Celera Discovery Systems, CA; July 2003 Assembly), Ensembl Mouse SNPView
(v33), and Entrez SNP (EntrezSNP) databases. Once the SNPs
were identified, a computational approach was used to determine if the SNP within the Id2 promoter (rs4229289, for sequence variation and genomic context see Ensembl Mouse
SNPView) was within a transcription factor binding site. First,
we determined whether the rs4229289 SNP was located within
a highly conserved region using Genome Browser Conservation tool (Mouse May 2004 Assembly). Second, we obtained
a highly conserved sequence around the rs4229289 SNP from
the alignment of mouse, rat, and human sequences using Genome Browser Conservation tool (May 2004 Assembly).
Alignments with other species were not available. Third, we
located putative transcription factor binding sites within the
conserved region using the vertebrate TRANSFAC database
available through MOTIF database and using the default cutoff score [23].
Several online databases provide transcript data or transcript distribution in the CNS. Gene Expression Omnibus
(GEO) is a high-throughput gene expression abundance data
repository, as well as a curated, online resource for gene expression data browsing, query, and retrieval. Retina Developmental Gene Expression (RetDevGE) describes the gene expression profile of thousands of genes in the developing postnatal mouse retina that were analyzed by hybridization to
Affymetrix Mu74 Av2 [21]. Mouse Retina SAGE
(MouseRetSAGE) Library provides serial analysis of gene
expression tags or in situ hybridization images for a limited
number of transcripts expressed in the developing and adult
mouse retina [24]. Gene Expression Nervous System Atlas
(GENSAT) maps the transcript distribution in the mouse CNS
using in situ hybridization.

2). These results suggested a generalized group of transcript
changes that occurs in the CNS after injury.
The acute phase genes belong to several transcript categories including transcription, cytokines, cell adhesion, extracellular proteases, and metabolism. The major transcript
group (46.6%) was related to the regulation of gene expression including transcription factors and transcription modulators. Based on gene expression dynamics, acute phase genes
displayed either transient or chronic expression changes after
retinal injury (Table 2). For example, transcription factors such
as Crem, Egr1, Fos, Fosl1, Junb, Egr1, Ier3, Btg2, Atf3, and
Nr4a1 were upregulated, with a transient surge at 4 h. Other
transcription factors such as Irf1, Stat3, Nfkb1, Id2, and Cebpd
displayed an upregulation at 4 h, followed by a smaller, but
sustained, expression out to 30 days after retinal injury (Table
2).
Regulatory locus analyses: The grouping of genes with
similar transcript expression changes suggested the presence
of common upstream modulators. To begin defining regulatory mechanisms controlling the retinal injury response, we
tested the hypothesis that acute phase genes share common
regulatory loci (Figure 1). Transcriptome-wide regulatory loci
for the mouse brain were mapped previously by our group
[9,11] and can be replicated and recomputed using the databases and genetic analysis tools at GeneNetwork. We used the
mouse brain transcriptome and genetic analysis at
GeneNetwork to define common regulatory loci for acute phase
genes.
A genome-wide scan estimates the association of transcript abundance variability against genetic markers across the
TABLE 1. DATA USED TO DEFINE ACUTE PHASE GENES
Tissue
---------Injured
retina

RESULTS
Acute phase genes: In our continuing efforts to understand
the retinal response to injury, we concentrated on the
transcriptome changes that occur within hours after retinal
injury: the acute phase genes. We know that there is a sequence
of changes leading to reactive gliosis and remodeling of the
retina [1]. To make our analysis more robust and generalized
for CNS injury, we combined our injured rat retina data with
results from injured rat brain and spinal cord. In these three
data sets, 30 genes demonstrated a significant change in expression level (Table 2; p<0.05; change>2 fold 4 h after injury). All of the common changes in the three data sets were
upregulated after injury. No common downregulated transcripts were observed in injured retina, brain, and spinal cord.
These acute phase genes can be expressed in a wide range of
neural cells including astrocytes, microglia, and neurons (Table

Reactive
response
inducer
-----------Retinal tear

Species
------Rat

Microarray
platform
---------U34A

Experimental
conditions
-----------4 h; and 1,
3, 7, & 30 d

GEO number,
website,
or reference
-----------------GSE1001 [1]

Injured
brain

Cortical
impact

Rat

U34A

3 h

GSE1911 [6,7]

Injured
spinal
cord

Cord
contusion

Rat

U34A

4 h

GSE464 [8]

Optic
nerve head
astrocyte

Cell culture

Human

U95Av2

Cell culture

GDS532 [17]

Cortical
astrocyte

Cell culture

Rat

U34A

Cell culture

GSM34300

Brain
microglia

Cell culture

Rat

U34A

Cell culture

[18,19]

Neuron

Cell culture

Mouse

U74Av2

Cell culture

JAJohnson [20]

Developing
retina

Development

Mouse

U74Av2

P0, P4, P8,
P10, P12,
P14, P21,
& adult

RetDevGE [21]

Adult
forebrain

Genetic
variation

Mouse

U74Av2

C57BL/6,
DBA2/J, F1,
& 32 BXD
RI strains

[9,12]

We performed a meta-analysis of previous experimental data to select a group of acute phase genes that are part of a common response
to injury in neural tissues. Previously, we examined transcript levels
in injured retina, injured brain, cultured astrocytes, and in forebrains
from a panel of 35 BXD RI strains [1,6,7,9,12,17]. Microarray data
sets describing transcript levels in injured spinal cord, cultured microglia, cultured neurons, and developing retina were obtained from
publicly available published studies [8,18-21]. All datasets are available online at Gene Expression Omnibus (GEO).
960
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mouse genome. For example, the abundance variability of Id2
was high in brains from BXD RI mouse strains (F34,99=5.2;
probe set 93013_at for Id2 mRNA). In the genome-wide scan
(Figure 1A), the correlation of Id2 variability across the mouse
genome is indicated by the likelihood ratio statistic curve (LRS;
blue line). At Chromosome 12, 10-30 Mb distal to the centromere, Id2 variation correlated highly with genetic markers
D12Mit209, D12Nyu7, Rrm2, D12Mit234, and D12Mit242
(Figure 1A, LRS=44). In a second example, Fos displayed
variation (F34,99=1.5; probe set 160901_at) that also correlated
with genetic markers that span a region of Chromosome 12 at
10-30 Mb (Figure 1A, LRS=13). The correlation of Fos and
Id2 expression to a chromosomal interval on Chromosome 12
suggested that this locus contains one or more polymorphic
genes that affect the levels of both transcripts.
In the group of acute phase genes, a number of transcripts
had a common regulatory locus on Chromosome 12. These
included Fos, Nr4a1, Id2, Egr1, Crem, Junb, Ccl3, and Ptpn16,
all of which shared a strong correlation to the locus on Chromosome 12, 10-30 Mb (Figure 1B, LRS>10; probe sets
160901_at, 102371_at, 93013_at, 98579_at, 160526_at,
102362_at, 102424_at, and 104598_at, respectively). By aligning genome-wide scans, we identified a strong band of regulatory loci (Figure 1B). Most of the genes (Fos, Nr4a1, Egr1,
Crem, Junb, Ccl3, and Ptpn16) regulated by this genomic location are found outside the regulatory locus, termed “transregulatory locus.” One of the genes, Id2, lies within the regulatory locus (orange arrowhead, Chromosome 12 at 20.1 Mb;
Figure 1). This is termed a “cis-regulatory locus” for Id2. Transcripts genetically linked to the same regulatory locus are part
of a genetic network [9]. In this case, Fos, Nr4a1, Id2, Egr1,
Crem, Junb, Ccl3, and Ptpn16 are part of a genetic network
that is controlled by the regulatory locus on Chromosome 12,
10-30 Mb. In addition to the regulatory locus on Chromosome
12, we identified two additional loci that may regulate transcript levels of acute phase genes (Figure 2). These regulatory
loci were located on Chromosomes 6 and 14. In some cases,
transcripts correlated to multiple regulatory loci. For example,
Fos and Nr4a1 were genetically linked to regulatory loci on
Chromosomes 6 and 12, whereas, Nfkb1 and Scya2 correlated
with regulatory loci on Chromosome 6 and Chromosome 14.
The genetic relationships between transcript variation and
genomic loci defined three genetic networks controlling the
expression of acute phase genes in mouse forebrains (Figure
2). The regulators for these genetic networks are located within
the regulatory loci on Chromosomes 6, 12, and 14.
Evaluating candidate upstream regulators: Once a regulatory locus was identified, the third step in our analysis refined the genomic location responsible for the mapping to this
chromosomal interval. Within each regulatory locus, a genomic
element generates the variation in expression of acute phase
genes. Ultimately, the genomic differences between the
C57BL/6 and DBA/2J mice underlie the transcript abundance
variability observed in BXD RI mouse strains. Since the BXD
RI mouse strain haplotypes are finely mapped and the parental genomes are sequenced, we have thorough SNP maps for
the 35 strains [9]. SNPs affecting the expression of acute phase

genes may be found in a number of genomic elements including promoters, enhancers, exons, or introns. These genomic
elements may affect the transcript levels of the upstream reguTABLE 2. ACUTE PHASE GENES EXPRESSED IN THE INJURED CNS
Symbol
--------

Name (alias)
-------------------

Astrocytic
expression
----------

Microglial
expression
----------

Neuronal
expression
----------

Chronic
expression
----------

Transcription
Atf3

Activating
transcription
factor 3

+

+

-

-

Btg2

B-cell
translocation gene
2

+

-

+

-

Crem

cAMP responsive
element modulator

-

-

-

-

Egr1

Early growth
response 1
(Krox-24/NGFI-A)

+

-

+

-

Fos

FBJ osteosarcoma
oncogene

+

+

+

-

Fosl1

Fos-like 1

+

-

-

-

Junb

Jun-B oncogene

+

-

+

-

Ier3

Immediate early
response 3 (PRG1)

+

+

+

-

Nr4a1

Nuclear receptor
subfamily 4a1
(NGFI-B/nurr7)

+

-

+

-

Cebpd

CCAAT/enhancer
binding protein
delta

+

-

+

+

Id2

Inhibitor of DNA
binding 2 (Idb2)

+

+

+

+

Irf1

Interferon
regulatory factor 1

+

+

-

+

Nfkb1

Nuclear factor
kappa B p105

+

+

-

+

Stat3

Signal transducer
and activator of
transcription 3

+

-

+

+

Cxcl10

Chemokine (C-X-C
motif) ligand 10

+

+

-

+

Il1a

Interleukin 1 alpha

-

+

-

-

Il1b

Interleukin 1, beta

-

+

-

+

Scya2

Small inducible
cytokine A2 (Ccl2)

-

+

-

-

Scya3

Small inducible
cytokine A3 (Ccl3)

+

-

-

-

Cytokine

Cell adhesion/ECM
Cd44

Cd44 antigen

+

+

-

+

Icam1

intercellular
adhesion molecule-1

+

+

-

+

Plat

Plasminogen
activator tissue

+

+

-

+

Serpine1

Serine proteinase
inhibitor-1 (Pai1)

+

-

-

+

Timp1

Tissue inhibitor of
metalloproteinase-1

+

+

-

+

Hmox1

Heme oxygenase

+

+

+

+

Mat2a

Methionine
adenosyltransferase
IIa

+

-

-

-

Ptgs2

Prostaglandin
synthase 2 (Cox-2)

+

-

-

-

Ptpn16

Tyrosine
phosphatase
nonreceptor type
16 (Dusp1/Ptp)

+

-

+

-

Ifrd1

interferon-related
developmental
regulator 1

+

-

+

-

Metabolism

Other

Acute phase genes displayed transcript changes in injured retina, brain,
and spinal cord. Astrocytic, microglial, and neuronal expressions refer to moderate to high transcript levels in cultured astrocytes [17,20],
microglia [18,19], and neurons [20].
961
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lator. Hundreds or even thousands of SNPs may lie within a
regulatory locus. Using simple rules helps to select a candidate gene. For example, a candidate gene lies within the regulatory locus, displays SNPs, and is functionally relevant to the
genes correlating to the regulatory locus. Biological significance of SNPs can be queried using programs that predict
whether SNPs affect known DNA binding sites or protein sequence motifs [23]. The vast biological content within online
resources provides a powerful tool to identify the regulatory
element controlling the expression of genes within a biological pathway, in our case the response of the transcriptome to
retinal injury. We present our analysis of candidate regulators

©2005 Molecular Vision

for several of the loci. We conclude with evidence for a strong
candidate gene for the regulatory locus on Chromosome 12.
The regulatory locus on Chromosome 14, 35-65 Mb,
modulates the transcript variability of transcription factors
Stat3, Nfkb1, and Irf1; cytokines Il1b and Scya2; and development-related gene Adfp (Figure 3A, probe sets 102736_at,
103486_at, 161281_f_at, 161443_r_at, 93858_at, 98427_s_at,
and 99099_at). This is a trans-regulatory locus for these genes,
as they all lie outside this locus. A genomic element within
the locus is a trans-regulator for these acute phase genes.
Within this locus, there were 315 positional candidate genes
(Figure 3B,C). A simple procedure to weigh the relevance of

Figure 1. Acute phase genes are modulated by distinct regulatory loci. We used the genetic analysis of transcript expression at GeneNetwork
to define genomic loci that control transcript abundance variability in mouse brains. At the heart of this analysis is a unique population of mice,
the recombinant inbred (RI) strains of mice. One group of mice were derived by inbreeding for over 20 generations the F1 crosses between
C57BL/6 and DBA/2J mouse strains. Each BXD RI strain has a shuffled genome consisting of a unique recombination of the C57BL/6 and
DBA/2J genomes, forming a segregating population of mice. These RI mouse strains, the associated microarray databases, and the geneticanalysis tools at GeneNetwork allow one to explore regulatory loci and networks built around any transcript [9-12]. The best way to think
about the genetic linkage mapping is at the transcript level. If there is specific variability in transcript abundance among members of a
segregating population, then it is possible to map transcript abundance to a specific chromosomal locus. Genetic linkage maps show that a
group of acute phase genes is controlled by a regulatory locus on Chromosome 12. A: Individual genome-wide maps for Id2 and Fos display
linkage of transcript variability (y-axis) to loci across the mouse genome (x-axis). Genetic analysis of transcript data from brain tissue was
determined in a panel of BXD recombinant inbred (RI) mouse strains [9,11]. Maps were generated by linking transcript variability against 779
genetic markers that are interspaced along the mouse genome by an average of 4 Megabase pairs (Mb). The alternating white and blue columns
represent chromosomes. The linkage between transcript variation and genetic differences at a particular genetic locus is measured in terms of
likelihood ratio statistic (LRS; solid blue line). Dashed horizontal lines mark transcript-specific significance thresholds for genome-wide
p<0.05 (significant, blue) and genome-wide p<0.63 (suggestive, green). Orange triangle indicates gene location. B: Multiple parallel genomewide maps display linkage using color hues with yellow and red bands representing suggestive and significant LRS. A common regulatory
locus on Chromosome 12 is identified for selected acute phase genes. Within this locus, there is a genomic element modulating the expression
of acute phase genes such as Fos, Junb, and Egr1. Individual and multiple genome-wide maps were generated using the tools at GeneNetwork.
Orange triangles indicate gene location. Linkage maps were generated using the Interval Mapping and Cluster Tree tools at GeneNetwork
(UTHSC Brain mRNA U74Av2 HWT1PM; December 2003).
962
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756-8, 762-3, 768-70, 774-6, 780-1, 788, 792-4, 804-6, 8112, 816-7). The presence of SNPs further supported the role of
Rnase4, AW045965, M6a, and Ndrg2 as candidate upstream
regulators. The use of transcriptome data from developing
mouse retina [21,24] or injured rat retina [1] can be valuable
in determining whether a candidate gene plays a role in controlling acute phase genes in the retina. In murine models of
retinal development [21,24], Ndrg2 displayed moderate transcript levels as early as postnatal day 4 and was expressed in
the adult retina (Figure 3E; data available at RetDevGE [21]
and MouseRetSAGE Library [24]). In contrast, Rnase4,
AW045965, and M6a were absent from birth through adult
retinal stages (data available at RetDevGE). Using a suite of
computational tools and transcriptome data from CNS gene
regulation and development, we defined Ndrg2 (N-myc downstream regulated gene 2) as a positional candidate that displayed a cis-regulatory locus in the mouse brain and cerebellum and that has a high SNP density. At the present time, Ndrg2
is the best candidate gene for the regulatory locus on Chromosome 14 and for potentially being a regulator of retinal
acute genes. Ndrg2 displays a conserved self-regulatory role
in mouse brain and cerebellum. It is expressed in the developing mouse retina during the critical time of cell proliferation
and cell specification. It is expressed in the developing mouse
retina during the critical time of cell proliferation and cell specification. It displays persistent transcript expression in the adult
mouse retina.
The regulatory locus on Chromosome 6 at 105-132 Mb
also controls the expression of acute phase genes such as Fosl1,
Scya2, Nr4a1, Fos, Nfkb1, Icam1, and Timp1 (Figure 4A; probe
sets 102371_at, 102736_at, 160901_at, 99835_at, 101141_at,
98427_s_at, and 101464_at). Within the locus, there were 315
positional genes (Figure 4B). Using the computational and
comparative techniques described above, Ccnd2 (Cyclin D2)
best met the criteria for a candidate upstream regulator. Ccnd2
displayed significant transcript abundance variability
(F34,99=3.8, Figure 4C, probe set 97504_at) and a strong cisregulatory locus on Chromosome 6 (LRS=29, Figure 4D) in
brains from BXD RI mouse strains. We also observed a strong
cis-regulatory locus for Ccnd2 in the cerebellum (LRS=15;
probe set 1416122_at_A; data not shown). Multiple SNPs
spanned the transcribed region of Ccnd2 (Celera SNP IDs
mCV24153285, 558, 560, 570, 580-2, 592-4, 615-6). These
data suggested that Ccnd2 might control the expression of classic acute genes in the CNS of BXD RI mouse strains. In the
mouse retina, Ccnd2 is expressed during development and
adult stages (data available at Mouse Retina SAGE Library
and GENSAT Image 14340). Moreover, Ccnd2 displayed
chronic upregulation in the injured rat retina (data available at
GEO data set GSE1001, probe set rc_AA899106_at [1]). Several data defined Ccnd2 as the best current candidate gene for
the regulatory locus on Chromosome 6 and for potentially
being a regulator of retinal reactive genes. It displays conserved self-regulatory role in mouse brain and cerebellum. It
is expressed in the developing mouse retina during the critical
time of cell proliferation and cell specification. It is expressed
in the developing mouse retina during the critical time of cell

a positional gene is to determine whether it displays significant transcript variability in BXD RI mouse strains and whether
its variability maps to its gene location: That is, does the gene
display a cis-regulatory locus? Highly variable transcripts included Rnase4, AW045965, M6a, Boct, Dad1, Ctsb, Cnih, and
Ndrg2 (F34,99>4). Of these, Rnase4, AW045965, M6a, Boct,
Boct, Cnih, and Ndrg2 linked strongly to the regulatory locus
on Chromosome 14 (LRSs>17; Figure 3D; data for Ndrg2
shown, probe set 96088_at). To further evaluate the role of
these positional genes, we determined whether their self-regulatory role extended to the cerebellum of BXD RI mouse
strains. Rnase4, AW045965, M6a, and Ndrg2 displayed significant cis-regulatory loci on Chromosome 14, 35-65 Mb
(LRSs>12, data not shown; probe sets 96038_at, 100073_at,
104456_at, and 161610_at). These data suggested that the regulatory role of the locus on Chromosome 14 is conserved across
CNS tissues. Rnase4, AW045965, M6a, and Ndrg2 are candidate upstream regulators because they display cis-regulatory
loci.
Identifying the genes with SNPs also helps to identify the
candidate upstream regulator. The sequences for Rnase4,
AW045965, M6a, and Ndrg2 had multiple SNPs between the
C57BL/6 and DBA/2J strains. For example, Ndrg2 had a high
density of SNPs: 7 within the promoter (Celera SNPs IDs
mCV23555818, mCV23556083-5, mCV23556089-91), and
25 within exons and introns (Celera SNPs IDs mCV23555752,

Figure 2. Genetic networks controlling acute phase transcripts. Genetic networks were derived from transcripts sharing regulatory loci
in mouse brains. As shown in Figure 1, acute phase transcripts Fos,
Egr1, Nr4a1, Junb, Stat3, Id2, Crem, Ptpn16, and Scya3 are controlled by a genomic locus on Chromosome 12. We also showed in
Table 2 that these transcripts are part of a common phase response to
injury in retina, brain, and spinal cord. Transcripts genetically linked
to the same regulatory loci and highly regulated in injured CNS are
hypothesized to be part of a genetic network. In this diagram, lines
connecting specific genes to loci represent a correlation between transcript expression and the regulatory locus. The diagram also illustrates two networks controlled by genomic loci on Chromosomes 6
and 14.
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Figure 3. Evaluating candidate
genes within Chromosome 14 locus.
A: The transcript variability of Adfp,
Scya2, Irf1, Nfkb1, Il1b, Stat3, and
Cxcl10 in brains from BXD RI
mouse strains is genetically linked
to a regulatory locus on Chromosome 14. This network was generated by comparing genome-wide
scans that measure the linkage of
transcript variability across the
mouse genome, as described in Figure 1. These transcripts are also
upregulated as acute phase transcripts in retina, brain and spinal
cord (Table 2). Transcripts genetically linked to the same regulatory
loci and highly regulated in injured
CNS are hypothesized to be part of
a genetic network. B: The combined
genome-wide map shows that their
transcript expression has a strong
genetic linkage to a locus within
Chromosome 14. The genome wide
scan, zoomed at Chromosome 14,
shows the genetic linkage (y-axis,
likelihood ratio statistic [LRS])
across the chromosome (x-axis,
Megabase pairs [Mb]). The locus
(35 to 65 Mb) includes 315 genes,
some of which have a high or low
single nucleotide polymorphism
(SNP) density. SNP density is denoted by the height of the orange
lines on the x-axis. Several rules
may help in selecting candidate gene
responsible for this regulatory locus.
The first rule is there have to be
SNPs present within the coding or
regulatory region of the gene of interest. As a first approximation we
used SNP density that is displayed
at the bottom of panel B and D. The
second rule is a high degree of transcript abundance variability in the BXD RI strains (illustrated in C). C: Transcript abundance variability in normal forebrains of BXD RI
mouse strains is due to genetic polymorphisms between the parental C57BL/6 and DBA/2J mouse strains. The graph illustrates transcript
abundance variability (y-axis) for genes (dots) within the 35 to 65 Mb interval of Chromosome 14 (x-axis). For a transcript to be mapped its
abundance must vary across the BXD RI mouse strains. The higher the variation in transcript abundance the more likely that the gene is a
candidate. Furthermore we expect that the variability is due to a polymorphism in the candidate gene, suggesting that the polymorphic gene is
modulating its own expression level (that is, a “cis-regulatory locus”). We measured transcript variability using an analysis of variance
(ANOVA) that tests the between-strain variance compared with the total variance for 100 arrays from 35 mouse strains. The degrees of
freedom for the between-group and total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when F34,99>1.5. In the graph,
each dot represents a gene with its variability measured by the ANOVA F-statistic (y-axis) and its genomic location within Chromosome 14
described in Mb. Rnase4, AW045965, M6a, Boct, Dad1, Ctsb, Cnih, and Ndrg2 are polymorphic genes that displayed significant transcript
variability and cis-regulatory loci in normal forebrains of BXD mouse strains. D: The third criterion identifies the genes that display self
regulation across CNS tissues. For example, the transcript variability of Ndrg2 (red circle in C) displayed a cis-regulatory locus in brain
(LRS=38, probe set 96088_at) and cerebellum (LRS=13, probe set 1448154_at_A) of BXD RI mouse strains. Here we illustrate linkage of
Ndrg2 transcript variability in BXD RI mouse strains across Chromosome 14. Red triangle indicates gene location. Rnase4, AW045965, and
M6a also displayed cis-regulatory loci in brain and cerebellum (data available at GeneNetwork). E: The fourth criterion deals with the biology
of the system. Meta-analyses of transcript levels during retinal development and retinal injury can help determine if a candidate gene is a
potential regulator in the retina. For example in murine models of retinal development, Ndrg2 displayed moderate transcript levels as early as
postnatal day 4 and was highly expressed in the adult retina. In contrast, Rnase4, AW045965, and M6a were absent from birth through adult
stages. Normalized expression data for Ndrg2 (y-axis) during murine retinal development (x-axis) is available at RetDevGE [21].
964

Molecular Vision 2005; 11:958-70 <http://www.molvis.org/molvis/v11/a115/>

©2005 Molecular Vision

Figure 4. Evaluating candidate genes within Chromosome 6 locus. A: The transcript variability of Scya2, Nfkb1, Fosl1, Timp1, Fos, Nr4a1,
and Icam1 in brains from BXD RI mouse strains is genetically linked to the regulatory locus on Chromosome 6. This network was generated
by comparing genome-wide scans that measure the linkage of transcript variability across the mouse genome, as described in Figure 1. These
transcripts are also upregulated as acute phase transcripts in retina, brain and spinal cord (Table 2). Transcripts genetically linked to the same
regulatory loci and highly regulated in injured CNS are hypothesized to be part of a genetic network. B: The combined genome-wide map
shows that their transcript expression has a strong genetic linkage to a locus within Chromosome 6, 105 to 132 Mb. The genome wide scan,
zoomed at Chromosome 6, shows the genetic linkage (y-axis, likelihood ratio statistic [LRS]) across the chromosome (x-axis, Megabase pairs
[Mb]). This locus includes over 200 positional genes, some of which have a high or low single nucleotide polymorphism (SNP) density. SNP
density is denoted by the height of the orange lines on the x-axis. Several rules may help in selecting candidate gene responsible for this
regulatory locus. The first rule is there have to be SNPs present within the coding or regulatory region of the gene of interest. As a first
approximation we used SNP density that is displayed at the bottom of panel B and D. The second rule is a high degree of transcript abundance
variability in the BXD RI strains (illustrated in C). C: Transcript abundance variability in normal forebrains of BXD RI mouse strains is due
to genetic polymorphisms between the parental C57BL/6 and DBA/2J mouse strains. The graph illustrates transcript abundance variability (yaxis) for genes (dots) within the 105 to 132 Mb interval of Chromosome 6 (x-axis). The higher the variation in transcript abundance the more
likely that the gene is a candidate. Furthermore we expect that the variability is due to a polymorphism in the candidate gene, suggesting that
the polymorphic gene is modulating its own expression level (that is, a “cis-regulatory locus”). We measured transcript variability using an
analysis of variance (ANOVA) that tests the between-strain variance compared with the total variance for 100 arrays from 35 mouse strains.
The degrees of freedom for the between-group and total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when F34,99>1.5.
In the graph, each dot represents a gene with its variability measured by the ANOVA F-statistic (y-axis) and its genomic location within
Chromosome 6 described in Mb. Tulp3, Ccnd2, Tead4, and Atp2b2 are polymorphic genes that displayed significant transcript variability and
cis-regulatory loci in normal forebrains of BXD mouse strains. D: The third criterion identifies the genes that display self regulation across
CNS tissues. For example, the transcript variability of Ccnd2 (red circle in C) displays a strong cis-regulatory locus in the forebrain (LRS=25,
probe set 97504_at) and cerebellum (LRS=14, probe set probe set 1416122_at_A) of BXD RI mouse strains. Here we illustrate linkage of
Ccnd2 transcript variability in BXD RI mouse strains across Chromosome 6. Red triangle indicates gene location. Atp2b2, Tulp3, and Tead4
also displayed cis-regulatory loci in brain and cerebellum (data available at GeneNetwork). The role of a candidate gene as a modulator of the
Chromosome 6 and wound healing is further strengthen if its transcript is differentially expressed in injured CNS. Ccnd2 displays increased
transcript levels in injured rat retina (data available at GEO data set GSE1001, probe set rc_AA899106_at) [1].
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Figure 5. Evaluating candidate genes within
Chromosome 12 locus. A: The transcript
variability of Id2, Crem, Egr1, Fos, Nr4a1,
Junb, Ptpn16, and Icam1 in brains from
BXD RI mouse strains is genetically linked
to the regulatory locus on Chromosome 12.
This network was generated by comparing
genome-wide scans that measure the linkage of transcript variability across the mouse
genome, as described in Figure 1. These
transcripts are also upregulated as acute
phase transcripts in retina, brain and spinal
cord (Table 2). Transcripts genetically linked
to the same regulatory loci and highly regulated in injured CNS are hypothesized to be
part of a genetic network. B: The combined
genome-wide map shows that their transcript
expression has a strong genetic linkage to a
locus within Chromosome 12, 10 to 30 Mb.
The genome wide scan, zoomed at Chromosome 12, shows the genetic linkage (y-axis,
likelihood ratio statistic [LRS]) across the
chromosome (x-axis, Megabase pairs [Mb]).
This locus includes over 60 positional genes,
some of which have a high or low single
nucleotide polymorphism (SNP) density.
SNP density is denoted by the height of the
orange lines on the x-axis. Several rules may
help in selecting candidate gene responsible
for this regulatory locus. The first rule is
there have to be SNPs present within the
coding or regulatory region of the gene of
interest. As a first approximation we used
SNP density that is displayed at the bottom
of panel B and D. The second rule is a high
degree of transcript abundance variability in
the BXD RI strains (illustrated in C). C:
Transcript abundance variability in normal
forebrains of BXD RI mouse strains is due
to genetic polymorphisms between the parental C57BL/6 and DBA/2J mouse strains.
DBA2
GGTTCTTCCGCGTTCGAGCCAATACC
The graph illustrates transcript abundance
B6
GGTTCTTCCGCGTTCGAGCCAATGCC
variability (y-axis) for genes (dots) within
Rn.
GGTTCTTCCGCGTTCGAGCCAATGCC
the 10 to 30 Mb interval of Chromosome 12
Hs.
GGTTCTTCCGCGTTCGAGCCAATCCC
(x-axis). For a transcript to be mapped its
abundance must vary across the BXD RI
NF-Y binding site
GCCAATC
mouse strains. The higher the variation in
GCCAATG
transcript abundance the more likely that the
gene is a candidate. Furthermore we expect that the variability is due to a polymorphism in the candidate gene, suggesting that the polymorphic gene is modulating its own expression level (that is, a “cis-regulatory locus”). We measured transcript variability using an analysis of
variance (ANOVA) that tests the between-strain variance compared with the total variance for 100 arrays from 35 mouse strains. The degrees
of freedom for the between-group and total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when F34,99>1.5. In the
graph, each dot represents a gene with its variability measured by the ANOVA F-statistic (y-axis) and its genomic location within Chromosome 12 described in Mb. Lpin1 and Id2 are polymorphic genes that displayed significant transcript variability and cis-regulatory loci in
normal forebrains of BXD mouse strains. D: The third criterion identifies the genes that display self regulation across CNS tissues. For
example, the transcript variability of Id2 (red circle in C) displayed a cis-regulatory locus in the brain (LRS=44, probe set 93013_at) and
cerebellum (LRS=14; 1453596_at_A) of BXD RI mouse strains. Here we illustrate linkage of Id2 transcript variability in BXD RI mouse
strains across Chromosome 12. Red triangle indicates gene location. Lpin1 also displayed cis-regulatory loci in brain and cerebellum (data
available at GeneNetwork). E: The structure of the Id2 gene illustrates a SNP at the promoter region and four SNPs within the second intron.
F: The SNP within the promoter region (Ensembl SNPView ID rs4229289 and Celera SNP ID mC22302957) is located within a highly
conserved region and is adjacent to a nuclear transcription factor Y (NF-Y) binding site (TRANSFAC ID M00185). Gene structure was
obtained from Ensembl and GenomeBrowser. The TRANSFAC 5.0 database was accessed through the MOTIF website. Highly conserved
regions were defined using the GenomeBrowser Conservation tool (Mouse May 2004 Assembly).
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proliferation and cell specification. It displays chronic
upregulation in the injured rat retina.
For the network defined by the regulatory locus on Chromosome 12 (Figure 5A, probe sets 93013_at, 161802_i_at,
161716_at, 160526_s_at, 104598_at, 102424_at, 102371_at,
and 102362_i_at), the Inhibitor of DNA binding 2 (Id2) is the
best current candidate upstream regulator. First, the positional
candidate Id2 (Figure 5B; probe set 93013_at) showed significant variability and strong cis-regulatory locus in brains
from BXD RI mouse strains (F34,99=5.2, Figure 5C; and
LRS=44; Figure 5D). In the cerebellum, we also observed a
strong cis-regulatory locus for Id2 (LRS=13; probe set
1453596_at_A; data not shown). Second, while several cisregulated genes were located within the regulatory locus on
Chromosome 12 (for example, Lpin1 [probe set 98892_at]),
only Id2 was upregulated in the rat retina, brain, and spinal
cord after injury (Table 2). In the injured rat retina, Id2 also
displayed a chronic upregulation even after 30 days postinjury
(Table 2; data available at GEO data set GSE1001, probe set
rc_AI230256_at). Id2 was also highly expressed during mouse
retinal development at the time of high levels of cell proliferation and remained present in the adult mouse retina (data
available at Retina Developmental Gene Expression and
Mouse Retina SAGE Library). Third, we located one SNP for
Id2 within the promoter and four SNPs within the second intron (Figure 5D; Ensembl gene ID ENSMUSG00000020644).
An SNP within the promoter region of Id2 may alter the ability of a transcription factor to modulate Id2 transcription.
We used in silico promoter analysis to define the transcription factor binding site affected by the SNP (Ensembl
SNPView ID rs4229289 and Celera SNP ID mC22302957).
Located 320 base pairs upstream of the starting codon, the
SNP consisted of an adenine-guanine (A/G) substitution between the DBA/2J and C57BL/6. The SNP was also located
in a highly conserved region across mouse, rat, and human
orthologs (Figure 5F). Using the MOTIF database, we determined that the SNP sits next to a CCAAT binding site
(TRANSFAC ID M00254), a likely binding site for nuclear
transcription factor (NF)-Y (TRANSFAC ID M00185). Based
on the TRANSFAC 5.0 database available through the MOTIF website, NF-Y binds to the CCAAT motif when the adjacent 3'-nucleotide is either G or C as seen in the C57BL/6, rat,
and human sequences for Id2 (Figure 5F). The nucleotide substitution of an A for a G/C may account for the lower Id2 levels seen in the DBA/2J and in all the BXD strains carrying the
DBA/2J haplotype. Several lines of evidence indicate that Id2
is a good candidate gene for the regulatory locus on Chromosome 12. Id2 is conserved and has a self-regulatory role in
mouse brain and cerebellum. It is expressed in the developing
retina during the critical time of cell proliferation and cell specification. It is upregulated immediately following injury to rat
retina, brain, and spinal cord.

tion presented here involves (1) highlighting robust injury
genes in multiple models of CNS trauma, (2) defining regulatory loci using genetic analysis of transcript data (that is, expression genetics [13]) from CNS tissues, and (3) predicting
candidate regulators using bioinformatic resources that are
available online. Using this approach, we defined a set of acute
phase genes that is commonly expressed in the retina, brain,
and spinal cord after traumatic injury. Our expression genetic
analyses revealed that regulatory loci on Chromosomes 6, 12,
and 14 control the expression of acute phase genes in brains
from BXD RI mouse strains. With the help of an array of online
bioinformatic tools, we identified three genetic networks and
candidate upstream regulators: Ndrg2, Ccnd2, and Id2.
Surprisingly, the changes controlled by these three loci
are present in a variety of different CNS tissues: retina, brain,
and spinal cord. This begs the question, are the networks controlled by the loci on Chromosomes 6, 12, and 14 unique to
the CNS? If one examines normal tissues, these regulatory
loci appear to be unique to the CNS. For example, expression
genetics of hematopoietic stem cells from BXD RI mouse
strains showed completely different sets of regulatory loci [10].
This is not surprising given the difference in expression patterns between CNS tissues and hematopoietic stem cells [9,10].
The same is true of the liver where Schadt and colleagues [25]
identified a different set of regulatory loci that did not correlate with our observations in the CNS. Although the specificity of expression-related regulatory loci in CNS, hematopoietic stem cells, and liver are different in normal resting conditions, we cannot exclude the possibility that some regulatory
mechanism are similar following trauma. Based upon our current data, the loci identified at chromosomes 6, 12, and 14
appear specific to the CNS.
Our method complements approaches that identify modules of co-regulated genes, shared cis-regulatory motifs, and
transcriptional factors binding to cis-regulatory motifs [26].
In reality, transcriptome changes during the wound-healing
response are controlled by a much more complex network [2730]. Our method holds the potential for identifying members
of genetic networks and regulators that may include gene products involved in mRNA stability, heterochromatin remodeling, transcriptional repression, and other regulatory mechanisms [9-12,25]. Indeed, even indirect modifiers of the transcriptional response to injury that are not transcription factors
can be identified using a genetic approach. Our analysis suggests, for example, that the expression of acute phase genes is
genetically linked to the transcript expression of three nontranscription factors including the hydrolase NDRG2, the
cyclin CCND2, and the dominant negative helix-loop-helix
protein ID2.
Key to defining modulators of regulatory networks in
BXD RI mouse strains is the genetic differences between parental strains. Genetic differences between C57BL/6 and DBA/
2J strains provide a powerful system to study regulators and
their targets, but this approach is limited to the detection of
polymorphisms between these strains. For some genes believed
to be involved in the response of the CNS to injury there are
no genetic differences between the BXD parental strains. For

DISCUSSION
Discovering mechanisms controlling retinal wound healing
from gene expression data is a promising and challenging task.
The method of extracting genetic networks and gene regula967
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example, STAT3 (a potent activator of acute phase genes such
as Fos [31,32]) has no SNPs in the coding or regulatory regions when the sequence of Stat3 of C57BL/6 strain is compared to that of the DBA/2J strain. Consequently, expression
genetics of BXD RI mouse strains revealed no genetic linkage between the Stat3 locus and genes known to be associated
with its regulation such as Fos. To provide a fuller examination of the networks controlling retinal wound healing the BXD
RI strains can be supplemented by studying additional strains.
Other RI strains of mice can be equally valuable. The BXA
and AXB RI strains were produced from crosses of the C57BL/
6 (B) and A/J (A) mouse strains. Genetic differences between
these two strains can be used to map different regulatory loci.
One prime example of the use of the AXB RI strains comes
from a study of horizontal cell density. A 2 fold difference in
horizontal cell density was observed between C57BL/6 and
A/J mouse strains [33]. The genetic backgrounds of the A/J
mouse strains and RI strains derived from the C57BL/6 and
A/J mouse strains make it possible to map genetic loci controlling horizontal cell number and potentially the response of
horizontal cells to retinal injury. Undoubtedly as more genetically diverse sets of strains become available, transcriptomewide analysis combined with genetic analysis will yield additional regulatory loci. This type of analysis and the development of additional expanded RI strains of mice hold great
promise in the search for genetic networks controlling complex biological processes such as wound healing in the retina
and CNS.
Typically, a candidate upstream modulator within regulatory loci will display (1) high transcript variation that maps
onto its transcript location, that is, a cis-regulatory locus, (2)
polymorphisms between parental strains, and (3) a function
related to CNS disease or expression changes after CNS injury. Ndrg2, Ccnd2, and Id2 met the candidate gene criteria
for the regulatory loci on Chromosomes 14, 6, and 12, respectively. N-myc downstream regulated gene 2 (NDRG2) is found
at high protein levels in neurogenic regions of the adult rat
brain. In these regions, NDRG2 localizes to GFAP-positive
astrocytes or radial glia [34]. In humans, downregulation of
Ndrg2 is associated with glioblastoma [35]. High levels of
NDRG2 are often associated with senile plaques of
Alzheimer’s patients and cellular processes of dystrophic neurons [36]. Our meta-analyses of Ndrg2 using transcript data
from developing mouse retina showed that Ndrg2 was expressed during the time of cell proliferation and cell specification. These data suggest that NDRG2 may play a key role in
the proliferation of glia cells and the degeneration of neurons.
A second likely upstream candidate of CNS injury is cyclin
D2 (CCND2). Cyclin D2 phosphorylates the Rb protein of
the RB-E2F complex. Cyclin D2 binding to the Rb protein
allows the transcription factor E2F to enter the nucleus and
stimulate proliferation. During the development of the cerebellum, cyclin D2 is a marker of proliferating granule cell
precursors. Granule neurons are the principal neuronal component of cerebellum, and mice deficient in cyclin D2 show
decreases in the number of granule cells and stellate interneurons [37,38]. Our meta-analyses of Ccnd2 also indicated that

Ccnd2 was moderately expressed in cultured astrocytes from
the cortex and optic nerve, in the mouse developing retina,
and injured rat retina. The enhanced expression of cyclin D2
in the retina following trauma may contribute to reactive responses such as cellular proliferation.
The third and most promising upstream candidate of CNS
injury is the inhibitor of DNA binding 2 (ID2). Our analyses
suggest that changes in Id2 expression were a common theme
in many reactive CNS tissues. Based on our meta-analyses of
microarray data, Id2 was upregulated in rat retina, brain, and
spinal cord after mechanical injury. In rat models of glaucoma
[3], the dystrophic retina also upregulates Id2 (personal communication, Drs. Farid Ahmed and Stanislav Tomarev, NEI,
NIH). We have confirmed upregulation of Id2 transcript in
mouse retina after a mechanical and toxic injury (data not
shown). Optic nerve head astrocytes from patients suffering
glaucoma display higher Id2 transcript levels than astrocytes
from non-glaucomatous patients [39]. The role of ID2 as a
positive regulator of cell-cycle progression [40-42] is consistent with the proliferative response that occurs in retinal injury. A potential source for dividing cells in the inner nuclear
layer is the Müller cells [43-45]. When Müller cells enter the
cell cycle, they decrease the expression of cell cycle inhibitors, including the cyclin-dependent kinase inhibitor p27/Kip1
[43]. ID2 is known to negatively regulate the transcription of
cell cycle inhibitor genes, including p15, p16, and p21 [40].
ID2 downregulates expression of cell cycle inhibitors by preventing the interaction of basic helix-loop-helix (bHLH) transcription factors that promote the transcription of cell cycle
inhibitor genes [40]. Alternatively, ID2 may stimulate proliferation by binding to the unphosphorylated Rb protein, allowing the release of the transcription factor E2F. E2F in turn
activates genes involved in the G1 to S transition and hence
proliferation [40,41]. Re-entry into the cell cycle may also
indicate apoptotic activity [46]. ID2 is known to play a role in
neuronal apoptosis [47]. Cerebellar granule neurons upregulate
transcript and protein levels of ID2 during the onset of
apoptosis [47]. The expression of Id2 antisense RNA in neurons protects from apoptosis. Together these data suggest that
the increase in ID2 may stimulate cells of the INL into the
G1-S transition of the cell cycle either for proliferation or
apoptosis. We are currently using the genetic background offered by the BXD RI mouse strains to determine the role of
the Chromosome 12 locus and ID2 in retinal wound healing.
We have confirmed the variability of ID2 at the transcript and
protein level in retinas of BXD RI mouse strains (data not
shown). We are using high and low Id2 expressers to see the
effect of Id2 dose effect on wound healing events following
retinal trauma.
The novel combination of microarray analysis, expression genetics, and bioinformatics provides a new and powerful approach to defining regulatory elements in the genome.
Using this approach, we were able to generate specific, testable hypotheses defining pathways that regulate proliferative
and reactive responses in the retina and elsewhere in the CNS.
As more diverse gene expression data sets become available,
it is our belief that comparison of gene expression and regula968
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